Gene Symbol | Gene ID | Gene Info |
---|---|---|
ELF2
|
ENSG00000109381.15 | E74 like ETS transcription factor 2 |
GABPA
|
ENSG00000154727.6 | GA binding protein transcription factor subunit alpha |
ELF5
|
ENSG00000135374.5 | E74 like ETS transcription factor 5 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr4_140101526_140101712 | ELF2 | 3247 | 0.182990 | 0.83 | 6.1e-03 | Click! |
chr4_140072798_140072949 | ELF2 | 12267 | 0.154215 | 0.76 | 1.7e-02 | Click! |
chr4_140096292_140096506 | ELF2 | 1973 | 0.262165 | 0.69 | 4.0e-02 | Click! |
chr4_140059854_140060005 | ELF2 | 677 | 0.666122 | 0.68 | 4.2e-02 | Click! |
chr4_140059558_140059709 | ELF2 | 973 | 0.520980 | 0.65 | 5.7e-02 | Click! |
chr11_34585845_34585996 | ELF5 | 50568 | 0.138202 | -0.45 | 2.3e-01 | Click! |
chr11_34530909_34531060 | ELF5 | 2362 | 0.333857 | 0.36 | 3.4e-01 | Click! |
chr11_34531289_34531440 | ELF5 | 1982 | 0.373301 | 0.25 | 5.2e-01 | Click! |
chr11_34523972_34524136 | ELF5 | 9292 | 0.215047 | 0.24 | 5.3e-01 | Click! |
chr11_34523137_34523454 | ELF5 | 10051 | 0.212220 | 0.23 | 5.6e-01 | Click! |
chr21_27095426_27095577 | GABPA | 11380 | 0.203078 | 0.48 | 1.9e-01 | Click! |
chr21_27095126_27095277 | GABPA | 11680 | 0.202445 | 0.45 | 2.3e-01 | Click! |
chr21_27095647_27095798 | GABPA | 11159 | 0.203551 | 0.44 | 2.3e-01 | Click! |
chr21_27073946_27074097 | GABPA | 32860 | 0.154932 | 0.43 | 2.5e-01 | Click! |
chr21_27089973_27090124 | GABPA | 16833 | 0.191990 | 0.36 | 3.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_51886452_51886750 | 2.17 |
FRMD6 |
FERM domain containing 6 |
69254 |
0.11 |
chr20_5668640_5669158 | 1.89 |
C20orf196 |
chromosome 20 open reading frame 196 |
62140 |
0.12 |
chr22_26969682_26970165 | 1.78 |
TPST2 |
tyrosylprotein sulfotransferase 2 |
8231 |
0.16 |
chr2_7144407_7144808 | 1.77 |
RNF144A |
ring finger protein 144A |
7536 |
0.26 |
chr15_66906180_66906636 | 1.75 |
RP11-321F6.1 |
HCG2003567; Uncharacterized protein |
31880 |
0.13 |
chr1_42195372_42195655 | 1.71 |
HIVEP3 |
human immunodeficiency virus type I enhancer binding protein 3 |
28841 |
0.2 |
chr12_11748797_11749209 | 1.66 |
ENSG00000251747 |
. |
49590 |
0.13 |
chr13_110305002_110305229 | 1.65 |
LINC00676 |
long intergenic non-protein coding RNA 676 |
75514 |
0.12 |
chr1_172485166_172485402 | 1.65 |
SUCO |
SUN domain containing ossification factor |
16205 |
0.21 |
chr14_101129324_101129521 | 1.64 |
DLK1 |
delta-like 1 homolog (Drosophila) |
62620 |
0.06 |
chrX_147398450_147398825 | 1.62 |
AC002368.4 |
|
183498 |
0.03 |
chr20_5154346_5154760 | 1.58 |
CDS2 |
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2 |
4915 |
0.2 |
chr8_53080963_53081315 | 1.55 |
RP11-26M5.3 |
|
17759 |
0.22 |
chr19_2622358_2622665 | 1.55 |
CTC-265F19.3 |
|
9441 |
0.14 |
chr17_32570710_32570941 | 1.54 |
CCL2 |
chemokine (C-C motif) ligand 2 |
11479 |
0.13 |
chr5_134769606_134770119 | 1.53 |
C5orf20 |
chromosome 5 open reading frame 20 |
13176 |
0.14 |
chr1_27440484_27440912 | 1.52 |
SLC9A1 |
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 |
40275 |
0.14 |
chr16_87849935_87850253 | 1.51 |
RP4-536B24.2 |
|
20044 |
0.16 |
chr20_48888390_48888572 | 1.48 |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
81105 |
0.08 |
chr6_90111426_90111593 | 1.48 |
RRAGD |
Ras-related GTP binding D |
10280 |
0.19 |
chr10_98416850_98417114 | 1.46 |
PIK3AP1 |
phosphoinositide-3-kinase adaptor protein 1 |
12386 |
0.2 |
chr11_64976530_64976899 | 1.44 |
CAPN1 |
calpain 1, (mu/I) large subunit |
25907 |
0.08 |
chr13_110308405_110308649 | 1.44 |
LINC00676 |
long intergenic non-protein coding RNA 676 |
72102 |
0.13 |
chr17_40109541_40109731 | 1.44 |
CNP |
2',3'-cyclic nucleotide 3' phosphodiesterase |
9123 |
0.12 |
chr5_177859454_177859724 | 1.43 |
CTB-26E19.1 |
|
10506 |
0.23 |
chr10_101604205_101604725 | 1.43 |
DNMBP |
dynamin binding protein |
53554 |
0.11 |
chr17_38123677_38123869 | 1.42 |
GSDMA |
gasdermin A |
1997 |
0.21 |
chr14_75150069_75150405 | 1.42 |
AREL1 |
apoptosis resistant E3 ubiquitin protein ligase 1 |
7319 |
0.16 |
chr1_92846574_92846807 | 1.42 |
ENSG00000242764 |
. |
21552 |
0.21 |
chr1_22454794_22454972 | 1.41 |
WNT4 |
wingless-type MMTV integration site family, member 4 |
1461 |
0.43 |
chr2_60530464_60530714 | 1.40 |
ENSG00000200807 |
. |
81151 |
0.1 |
chr17_34409205_34409760 | 1.40 |
AC069363.1 |
|
490 |
0.65 |
chr16_81789456_81789828 | 1.39 |
PLCG2 |
phospholipase C, gamma 2 (phosphatidylinositol-specific) |
16940 |
0.27 |
chr21_46963190_46963524 | 1.39 |
SLC19A1 |
solute carrier family 19 (folate transporter), member 1 |
957 |
0.61 |
chr22_39764623_39764959 | 1.36 |
SYNGR1 |
synaptogyrin 1 |
4616 |
0.16 |
chr3_46134937_46135139 | 1.35 |
XCR1 |
chemokine (C motif) receptor 1 |
65804 |
0.1 |
chr10_80011017_80011246 | 1.33 |
ENSG00000201393 |
. |
116133 |
0.07 |
chr17_77157383_77157714 | 1.33 |
RBFOX3 |
RNA binding protein, fox-1 homolog (C. elegans) 3 |
22006 |
0.18 |
chr2_20854096_20854280 | 1.32 |
HS1BP3 |
HCLS1 binding protein 3 |
3339 |
0.27 |
chr17_19206190_19206463 | 1.31 |
EPN2-AS1 |
EPN2 antisense RNA 1 |
3248 |
0.16 |
chr2_109891880_109892163 | 1.31 |
ENSG00000265965 |
. |
38060 |
0.21 |
chr3_184095207_184095533 | 1.30 |
THPO |
thrombopoietin |
558 |
0.59 |
chr9_115626618_115626769 | 1.28 |
RP11-408O19.5 |
|
20745 |
0.17 |
chr15_92133711_92133937 | 1.28 |
ENSG00000238981 |
. |
244785 |
0.02 |
chr3_148426073_148426436 | 1.27 |
AGTR1 |
angiotensin II receptor, type 1 |
10549 |
0.28 |
chr20_19535016_19535176 | 1.26 |
ENSG00000216017 |
. |
35735 |
0.21 |
chr20_8413517_8413855 | 1.26 |
ENSG00000221201 |
. |
176141 |
0.03 |
chrX_70383283_70383434 | 1.26 |
NLGN3 |
neuroligin 3 |
18646 |
0.11 |
chr2_223907840_223908197 | 1.26 |
KCNE4 |
potassium voltage-gated channel, Isk-related family, member 4 |
8514 |
0.28 |
chr3_52236468_52236805 | 1.25 |
ALAS1 |
aminolevulinate, delta-, synthase 1 |
4012 |
0.14 |
chr1_162199981_162200132 | 1.25 |
ENSG00000266144 |
. |
73159 |
0.08 |
chr1_31870163_31870721 | 1.24 |
SERINC2 |
serine incorporator 2 |
11970 |
0.15 |
chr6_116950762_116950913 | 1.24 |
RSPH4A |
radial spoke head 4 homolog A (Chlamydomonas) |
13050 |
0.16 |
chr19_18280291_18280598 | 1.24 |
IFI30 |
interferon, gamma-inducible protein 30 |
3528 |
0.13 |
chr14_69091155_69091432 | 1.23 |
CTD-2325P2.4 |
|
3869 |
0.31 |
chr15_42415254_42415667 | 1.23 |
PLA2G4D |
phospholipase A2, group IVD (cytosolic) |
28708 |
0.13 |
chr11_57542945_57543611 | 1.23 |
CTNND1 |
catenin (cadherin-associated protein), delta 1 |
5797 |
0.16 |
chr4_154581482_154581754 | 1.22 |
RP11-153M7.3 |
|
17793 |
0.19 |
chr18_33047119_33047417 | 1.21 |
INO80C |
INO80 complex subunit C |
20166 |
0.19 |
chr3_138581340_138581807 | 1.21 |
PIK3CB |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta |
27793 |
0.2 |
chr2_70031503_70031895 | 1.20 |
GMCL1 |
germ cell-less, spermatogenesis associated 1 |
25075 |
0.17 |
chr14_101308246_101309004 | 1.20 |
ENSG00000214548 |
. |
7020 |
0.04 |
chr4_144290634_144291022 | 1.20 |
GAB1 |
GRB2-associated binding protein 1 |
7150 |
0.23 |
chr15_75450423_75450619 | 1.19 |
ENSG00000252722 |
. |
36514 |
0.1 |
chr22_24845274_24845662 | 1.19 |
ADORA2A |
adenosine A2a receptor |
16660 |
0.15 |
chr8_6149074_6149420 | 1.19 |
RP11-115C21.2 |
|
114816 |
0.06 |
chr10_43578430_43578653 | 1.17 |
RET |
ret proto-oncogene |
6014 |
0.26 |
chr1_6975334_6975725 | 1.17 |
RP11-334N17.1 |
|
98810 |
0.07 |
chr11_33954017_33954252 | 1.16 |
LMO2 |
LIM domain only 2 (rhombotin-like 1) |
40298 |
0.16 |
chr11_9660806_9661115 | 1.16 |
SWAP70 |
SWAP switching B-cell complex 70kDa subunit |
24664 |
0.14 |
chr10_98416000_98416373 | 1.16 |
PIK3AP1 |
phosphoinositide-3-kinase adaptor protein 1 |
13182 |
0.2 |
chr8_134162105_134162300 | 1.14 |
TG |
thyroglobulin |
36455 |
0.15 |
chr16_13521427_13521778 | 1.14 |
AC003009.1 |
|
95162 |
0.09 |
chr3_167874614_167874935 | 1.13 |
ENSG00000266363 |
. |
46523 |
0.18 |
chr8_24206460_24207135 | 1.12 |
ADAM28 |
ADAM metallopeptidase domain 28 |
7632 |
0.22 |
chr20_23088063_23088315 | 1.12 |
CD93 |
CD93 molecule |
21212 |
0.17 |
chr19_14898095_14898371 | 1.12 |
EMR2 |
egf-like module containing, mucin-like, hormone receptor-like 2 |
8880 |
0.14 |
chr2_219337911_219338064 | 1.11 |
ENSG00000222714 |
. |
27773 |
0.11 |
chr15_75195081_75195345 | 1.11 |
CTD-2235H24.2 |
|
2880 |
0.15 |
chr1_221249282_221249543 | 1.10 |
HLX |
H2.0-like homeobox |
194828 |
0.03 |
chr2_89488681_89488919 | 1.10 |
IGKV3-25 |
immunoglobulin kappa variable 3-25 (pseudogene) |
3440 |
0.08 |
chr3_137854767_137854935 | 1.10 |
A4GNT |
alpha-1,4-N-acetylglucosaminyltransferase |
3622 |
0.23 |
chr19_52269762_52269913 | 1.10 |
FPR2 |
formyl peptide receptor 2 |
1794 |
0.24 |
chr12_117508880_117509031 | 1.09 |
TESC |
tescalcin |
24319 |
0.23 |
chr9_92195090_92195706 | 1.09 |
GADD45G |
growth arrest and DNA-damage-inducible, gamma |
24530 |
0.23 |
chrX_147691119_147691411 | 1.09 |
AFF2-IT1 |
AFF2 intronic transcript 1 (non-protein coding) |
62866 |
0.14 |
chr20_19437202_19437504 | 1.09 |
ENSG00000221748 |
. |
115413 |
0.06 |
chr11_61690283_61690510 | 1.09 |
RAB3IL1 |
RAB3A interacting protein (rabin3)-like 1 |
2655 |
0.18 |
chr22_30831835_30832018 | 1.08 |
MTFP1 |
mitochondrial fission process 1 |
10121 |
0.07 |
chr7_73629553_73629793 | 1.08 |
LAT2 |
linker for activation of T cells family, member 2 |
5320 |
0.17 |
chr1_8005023_8005246 | 1.08 |
TNFRSF9 |
tumor necrosis factor receptor superfamily, member 9 |
4208 |
0.2 |
chr11_46698113_46698718 | 1.08 |
ATG13 |
autophagy related 13 |
12865 |
0.13 |
chr2_207971459_207971636 | 1.08 |
ENSG00000253008 |
. |
3250 |
0.25 |
chr15_59823301_59823617 | 1.08 |
ENSG00000201704 |
. |
42962 |
0.12 |
chr11_126084700_126085013 | 1.08 |
ENSG00000222067 |
. |
483 |
0.66 |
chr17_29701155_29701367 | 1.07 |
NF1 |
neurofibromin 1 |
15695 |
0.14 |
chr16_57717963_57718157 | 1.07 |
CCDC135 |
coiled-coil domain containing 135 |
10645 |
0.12 |
chr12_63122461_63122667 | 1.07 |
ENSG00000238475 |
. |
77609 |
0.09 |
chr1_27840169_27840572 | 1.07 |
RP1-159A19.4 |
|
11946 |
0.17 |
chr20_58688912_58689063 | 1.06 |
C20orf197 |
chromosome 20 open reading frame 197 |
58007 |
0.14 |
chr12_2397196_2397863 | 1.06 |
CACNA1C-IT3 |
CACNA1C intronic transcript 3 (non-protein coding) |
18587 |
0.24 |
chr10_73542792_73542943 | 1.06 |
C10orf54 |
chromosome 10 open reading frame 54 |
9612 |
0.18 |
chr2_54666857_54667382 | 1.06 |
SPTBN1 |
spectrin, beta, non-erythrocytic 1 |
16303 |
0.24 |
chr7_41849206_41849814 | 1.06 |
AC005027.3 |
|
104577 |
0.07 |
chr12_123227379_123227565 | 1.05 |
DENR |
density-regulated protein |
9849 |
0.13 |
chr6_167184807_167185037 | 1.05 |
RPS6KA2 |
ribosomal protein S6 kinase, 90kDa, polypeptide 2 |
13523 |
0.26 |
chr17_9108377_9108663 | 1.05 |
RP11-85B7.2 |
|
26085 |
0.19 |
chr17_72044368_72044711 | 1.05 |
RPL38 |
ribosomal protein L38 |
155182 |
0.03 |
chr1_45466698_45467046 | 1.05 |
HECTD3 |
HECT domain containing E3 ubiquitin protein ligase 3 |
7351 |
0.14 |
chr2_64419005_64419239 | 1.04 |
AC074289.1 |
|
14987 |
0.24 |
chr15_64330125_64330282 | 1.04 |
DAPK2 |
death-associated protein kinase 2 |
2263 |
0.31 |
chr17_129724_129949 | 1.04 |
RP11-1260E13.1 |
|
41347 |
0.12 |
chr20_10484876_10485147 | 1.04 |
SLX4IP |
SLX4 interacting protein |
69060 |
0.11 |
chr3_53192591_53193057 | 1.04 |
PRKCD |
protein kinase C, delta |
2312 |
0.27 |
chr17_78261654_78261965 | 1.03 |
RNF213 |
ring finger protein 213 |
27140 |
0.13 |
chr19_51714203_51714354 | 1.03 |
SIGLEC22P |
sialic acid binding Ig-like lectin 22, pseudogene |
88 |
0.94 |
chr1_25198463_25198763 | 1.02 |
RUNX3 |
runt-related transcription factor 3 |
56999 |
0.12 |
chr16_626620_627028 | 1.02 |
PIGQ |
phosphatidylinositol glycan anchor biosynthesis, class Q |
2267 |
0.12 |
chr1_59756185_59756365 | 1.02 |
FGGY |
FGGY carbohydrate kinase domain containing |
6035 |
0.35 |
chr5_147183992_147184208 | 1.02 |
JAKMIP2 |
janus kinase and microtubule interacting protein 2 |
21762 |
0.17 |
chr17_25860020_25860171 | 1.01 |
KSR1 |
kinase suppressor of ras 1 |
49852 |
0.13 |
chr14_91148650_91148933 | 1.01 |
TTC7B |
tetratricopeptide repeat domain 7B |
4602 |
0.19 |
chr1_234985284_234985976 | 1.01 |
ENSG00000201638 |
. |
11910 |
0.26 |
chr10_101939847_101940043 | 1.01 |
ERLIN1 |
ER lipid raft associated 1 |
5841 |
0.15 |
chr1_3510128_3510517 | 1.01 |
MEGF6 |
multiple EGF-like-domains 6 |
17737 |
0.13 |
chr22_50540289_50540451 | 1.01 |
MOV10L1 |
Mov10l1, Moloney leukemia virus 10-like 1, homolog (mouse) |
11685 |
0.13 |
chr19_51746187_51746611 | 1.01 |
SIGLECL1 |
SIGLEC family like 1 |
3204 |
0.13 |
chr16_31141784_31142119 | 1.01 |
RP11-388M20.2 |
|
803 |
0.33 |
chr11_73077311_73077462 | 1.00 |
ENSG00000266866 |
. |
9206 |
0.14 |
chr7_128709200_128709351 | 1.00 |
ENSG00000238733 |
. |
7690 |
0.17 |
chr15_89710472_89711584 | 1.00 |
RLBP1 |
retinaldehyde binding protein 1 |
44046 |
0.12 |
chr17_34617095_34617334 | 1.00 |
CCL3L1 |
chemokine (C-C motif) ligand 3-like 1 |
8505 |
0.15 |
chr1_167571301_167571550 | 1.00 |
RCSD1 |
RCSD domain containing 1 |
27905 |
0.16 |
chr11_33981495_33981838 | 1.00 |
LMO2 |
LIM domain only 2 (rhombotin-like 1) |
67830 |
0.1 |
chr15_75761353_75761612 | 1.00 |
SIN3A |
SIN3 transcription regulator family member A |
13299 |
0.17 |
chr8_61816055_61816746 | 1.00 |
RP11-33I11.2 |
|
94235 |
0.09 |
chr14_65509694_65510092 | 1.00 |
ENSG00000266531 |
. |
1513 |
0.32 |
chr2_226986115_226986427 | 1.00 |
ENSG00000263363 |
. |
537238 |
0.0 |
chr1_54561699_54561850 | 0.99 |
AL161915.1 |
Uncharacterized protein |
8194 |
0.15 |
chr3_176939473_176939919 | 0.99 |
TBL1XR1 |
transducin (beta)-like 1 X-linked receptor 1 |
24435 |
0.24 |
chr4_74960064_74960382 | 0.99 |
CXCL2 |
chemokine (C-X-C motif) ligand 2 |
4787 |
0.18 |
chr9_141105098_141105281 | 0.99 |
TUBBP5 |
tubulin, beta pseudogene 5 |
35692 |
0.19 |
chr2_65378861_65379061 | 0.99 |
ENSG00000272025 |
. |
6835 |
0.21 |
chr1_236100778_236101119 | 0.99 |
ENSG00000206803 |
. |
22233 |
0.18 |
chr19_48998674_48999137 | 0.99 |
LMTK3 |
lemur tyrosine kinase 3 |
16156 |
0.09 |
chr19_3061531_3061797 | 0.98 |
AES |
amino-terminal enhancer of split |
262 |
0.86 |
chr2_192301147_192301752 | 0.98 |
MYO1B |
myosin IB |
25658 |
0.23 |
chr6_45503875_45504114 | 0.98 |
ENSG00000252738 |
. |
109847 |
0.06 |
chr18_9702219_9702424 | 0.98 |
RAB31 |
RAB31, member RAS oncogene family |
5841 |
0.24 |
chr21_40382908_40383154 | 0.98 |
ENSG00000272015 |
. |
116322 |
0.06 |
chr19_16974466_16974617 | 0.98 |
SIN3B |
SIN3 transcription regulator family member B |
456 |
0.73 |
chr8_68877220_68877489 | 0.98 |
PREX2 |
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2 |
13001 |
0.29 |
chr10_3110432_3110741 | 0.98 |
PFKP |
phosphofructokinase, platelet |
233 |
0.96 |
chr22_38126402_38126580 | 0.98 |
TRIOBP |
TRIO and F-actin binding protein |
15744 |
0.11 |
chr6_157814961_157815314 | 0.97 |
ZDHHC14 |
zinc finger, DHHC-type containing 14 |
12972 |
0.26 |
chr2_48492787_48493214 | 0.97 |
ENSG00000201010 |
. |
48286 |
0.14 |
chr12_12016346_12017014 | 0.97 |
ETV6 |
ets variant 6 |
22191 |
0.26 |
chr2_223656927_223657285 | 0.97 |
ACSL3 |
acyl-CoA synthetase long-chain family member 3 |
68546 |
0.11 |
chr5_88110935_88111169 | 0.97 |
MEF2C |
myocyte enhancer factor 2C |
8553 |
0.27 |
chr4_40350204_40350355 | 0.97 |
CHRNA9 |
cholinergic receptor, nicotinic, alpha 9 (neuronal) |
12933 |
0.2 |
chr8_72762424_72762575 | 0.97 |
MSC |
musculin |
5796 |
0.19 |
chr11_58991697_58991848 | 0.97 |
ENSG00000263999 |
. |
9600 |
0.16 |
chr2_69062364_69062558 | 0.97 |
AC097495.2 |
|
325 |
0.9 |
chr10_104358577_104358856 | 0.97 |
ENSG00000207029 |
. |
7435 |
0.17 |
chr10_77695413_77695615 | 0.96 |
ENSG00000215921 |
. |
111978 |
0.06 |
chr2_15260083_15260395 | 0.96 |
NBAS |
neuroblastoma amplified sequence |
70282 |
0.14 |
chr1_47709724_47709875 | 0.96 |
TAL1 |
T-cell acute lymphocytic leukemia 1 |
12412 |
0.15 |
chr15_67158530_67158864 | 0.96 |
SMAD6 |
SMAD family member 6 |
154662 |
0.04 |
chr10_82358915_82359164 | 0.96 |
SH2D4B |
SH2 domain containing 4B |
58464 |
0.13 |
chr17_8775973_8776124 | 0.96 |
PIK3R6 |
phosphoinositide-3-kinase, regulatory subunit 6 |
5054 |
0.22 |
chr16_30770688_30770839 | 0.96 |
C16orf93 |
chromosome 16 open reading frame 93 |
282 |
0.79 |
chr20_58720357_58720636 | 0.96 |
C20orf197 |
chromosome 20 open reading frame 197 |
89516 |
0.09 |
chr1_205206763_205207082 | 0.96 |
RP11-383G10.5 |
|
927 |
0.54 |
chr7_36312142_36312525 | 0.96 |
EEPD1 |
endonuclease/exonuclease/phosphatase family domain containing 1 |
24420 |
0.16 |
chr19_7733657_7733953 | 0.96 |
RETN |
resistin |
125 |
0.91 |
chr7_139942100_139942354 | 0.95 |
ENSG00000199283 |
. |
557 |
0.76 |
chr1_186873493_186873815 | 0.95 |
PLA2G4A |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
75532 |
0.13 |
chr1_59757690_59757841 | 0.95 |
FGGY |
FGGY carbohydrate kinase domain containing |
4545 |
0.37 |
chr11_68561332_68561520 | 0.95 |
CPT1A |
carnitine palmitoyltransferase 1A (liver) |
5310 |
0.23 |
chr3_143017913_143018247 | 0.95 |
RP13-635I23.3 |
|
15191 |
0.22 |
chr22_42793868_42794019 | 0.95 |
NFAM1 |
NFAT activating protein with ITAM motif 1 |
34458 |
0.15 |
chr11_126206487_126206715 | 0.95 |
ST3GAL4 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
18954 |
0.11 |
chr22_40877098_40877463 | 0.95 |
MKL1 |
megakaryoblastic leukemia (translocation) 1 |
17842 |
0.16 |
chr6_147233902_147234394 | 0.95 |
STXBP5-AS1 |
STXBP5 antisense RNA 1 |
1406 |
0.59 |
chr1_36953937_36954195 | 0.95 |
CSF3R |
colony stimulating factor 3 receptor (granulocyte) |
5187 |
0.19 |
chr8_60247884_60248322 | 0.95 |
ENSG00000201763 |
. |
120341 |
0.06 |
chr15_50698058_50698434 | 0.94 |
USP8 |
ubiquitin specific peptidase 8 |
18331 |
0.14 |
chr1_201538116_201538341 | 0.94 |
AC096677.1 |
Uncharacterized protein ENSP00000471857 |
53785 |
0.09 |
chr8_125042895_125043180 | 0.94 |
RP11-959I15.4 |
|
9672 |
0.19 |
chr9_124255457_124255640 | 0.94 |
ENSG00000240299 |
. |
1249 |
0.49 |
chr13_37011882_37012132 | 0.94 |
CCNA1 |
cyclin A1 |
5512 |
0.25 |
chr1_88337258_88337753 | 0.94 |
ENSG00000199318 |
. |
418449 |
0.01 |
chr2_110371638_110371846 | 0.93 |
SEPT10 |
septin 10 |
22 |
0.68 |
chr9_96919191_96919602 | 0.93 |
ENSG00000199165 |
. |
18838 |
0.15 |
chr4_3559984_3560135 | 0.93 |
LINC00955 |
long intergenic non-protein coding RNA 955 |
18537 |
0.17 |
chr12_11962461_11962612 | 0.93 |
ETV6 |
ets variant 6 |
57101 |
0.16 |
chr19_33750472_33750739 | 0.93 |
SLC7A10 |
solute carrier family 7 (neutral amino acid transporter light chain, asc system), member 10 |
33849 |
0.1 |
chr10_5644211_5644362 | 0.93 |
ENSG00000240577 |
. |
29140 |
0.14 |
chr20_33872479_33872715 | 0.93 |
EIF6 |
eukaryotic translation initiation factor 6 |
24 |
0.87 |
chr17_62408840_62409112 | 0.93 |
MILR1 |
mast cell immunoglobulin-like receptor 1 |
52593 |
0.1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.5 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.9 | 2.8 | GO:0032632 | interleukin-3 production(GO:0032632) |
0.7 | 1.5 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.7 | 2.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.7 | 2.1 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.7 | 2.0 | GO:0010193 | response to ozone(GO:0010193) |
0.7 | 2.6 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.6 | 2.6 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.6 | 1.2 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.6 | 1.2 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.6 | 1.8 | GO:0003078 | obsolete regulation of natriuresis(GO:0003078) |
0.6 | 1.7 | GO:0032898 | neurotrophin production(GO:0032898) |
0.6 | 0.6 | GO:0032661 | interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) |
0.6 | 1.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.6 | 1.7 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.6 | 1.7 | GO:0031394 | regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.6 | 1.7 | GO:0051014 | actin filament severing(GO:0051014) |
0.5 | 1.6 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.5 | 1.1 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.5 | 1.6 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.5 | 2.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.5 | 1.0 | GO:0060437 | lung growth(GO:0060437) |
0.5 | 4.0 | GO:0042119 | neutrophil activation(GO:0042119) |
0.5 | 2.0 | GO:0018101 | protein citrullination(GO:0018101) |
0.5 | 2.8 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.5 | 1.4 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.5 | 1.4 | GO:0009414 | response to water deprivation(GO:0009414) |
0.5 | 0.9 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.5 | 0.9 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.5 | 5.0 | GO:0010324 | phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
0.5 | 0.5 | GO:0009415 | response to water(GO:0009415) |
0.5 | 0.5 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.4 | 1.8 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.4 | 1.3 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.4 | 2.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.4 | 1.7 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.4 | 2.6 | GO:0045655 | regulation of monocyte differentiation(GO:0045655) |
0.4 | 1.7 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.4 | 0.4 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.4 | 1.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.4 | 1.2 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.4 | 2.4 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.4 | 2.0 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.4 | 1.6 | GO:0051852 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.4 | 0.4 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.4 | 2.7 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.4 | 1.9 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
0.4 | 1.8 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.4 | 1.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.4 | 2.2 | GO:0016322 | neuron remodeling(GO:0016322) |
0.4 | 1.5 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.4 | 1.1 | GO:0035583 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.4 | 0.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.4 | 0.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.4 | 1.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.3 | 0.7 | GO:0010447 | response to acidic pH(GO:0010447) |
0.3 | 2.8 | GO:0050957 | equilibrioception(GO:0050957) |
0.3 | 2.8 | GO:0015884 | folic acid transport(GO:0015884) |
0.3 | 3.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.3 | 2.7 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.3 | 0.7 | GO:0048245 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.3 | 1.0 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.3 | 0.6 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.3 | 0.3 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.3 | 1.2 | GO:0008228 | opsonization(GO:0008228) |
0.3 | 1.2 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.3 | 0.6 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.3 | 1.2 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.3 | 0.6 | GO:0002885 | positive regulation of hypersensitivity(GO:0002885) |
0.3 | 0.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.3 | 0.9 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 0.6 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.3 | 1.5 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.3 | 0.3 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.3 | 1.2 | GO:0043049 | otic placode formation(GO:0043049) |
0.3 | 0.9 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.3 | 0.8 | GO:0019532 | oxalate transport(GO:0019532) |
0.3 | 0.8 | GO:0001821 | histamine secretion(GO:0001821) |
0.3 | 0.6 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.3 | 0.8 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.3 | 0.8 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.3 | 1.4 | GO:0044144 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) negative regulation of growth of symbiont in host(GO:0044130) modulation of growth of symbiont involved in interaction with host(GO:0044144) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.3 | 1.9 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.3 | 1.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 1.1 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.3 | 0.8 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.3 | 1.1 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of leukocyte degranulation(GO:0043302) positive regulation of mast cell degranulation(GO:0043306) |
0.3 | 1.0 | GO:0045056 | transcytosis(GO:0045056) |
0.3 | 1.0 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.3 | 0.8 | GO:0032328 | alanine transport(GO:0032328) |
0.3 | 3.6 | GO:0050832 | defense response to fungus(GO:0050832) |
0.3 | 0.8 | GO:0048478 | replication fork protection(GO:0048478) |
0.3 | 0.8 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.3 | 0.3 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.3 | 0.8 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.3 | 0.5 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.3 | 0.5 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.3 | 0.8 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.3 | 0.5 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.2 | 1.0 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.2 | 0.2 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.2 | 0.5 | GO:0002540 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.2 | 1.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 0.7 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 1.4 | GO:1901998 | antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.2 | 0.5 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.2 | 0.7 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 1.0 | GO:0019695 | choline metabolic process(GO:0019695) |
0.2 | 0.5 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 1.2 | GO:0032782 | bile acid secretion(GO:0032782) |
0.2 | 0.5 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.2 | 0.5 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.2 | 1.6 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.2 | 0.7 | GO:0006903 | vesicle targeting(GO:0006903) |
0.2 | 0.2 | GO:0002125 | maternal aggressive behavior(GO:0002125) obsolete positive regulation of natriuresis(GO:0003079) |
0.2 | 0.7 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.2 | 0.7 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 0.2 | GO:0060157 | urinary bladder development(GO:0060157) |
0.2 | 0.2 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 1.4 | GO:0016265 | obsolete death(GO:0016265) |
0.2 | 0.5 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.2 | 0.7 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.2 | 0.7 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 0.2 | GO:1902622 | regulation of neutrophil chemotaxis(GO:0090022) regulation of neutrophil migration(GO:1902622) |
0.2 | 0.9 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 0.7 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.2 | 0.2 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.2 | 0.2 | GO:0090009 | primitive streak formation(GO:0090009) |
0.2 | 0.7 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.2 | 0.2 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 0.7 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.2 | 0.2 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.2 | 0.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.2 | 0.2 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 1.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.2 | 0.6 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.2 | 0.6 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.2 | 0.8 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.8 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 1.4 | GO:0052803 | histidine metabolic process(GO:0006547) imidazole-containing compound metabolic process(GO:0052803) |
0.2 | 0.8 | GO:0007549 | dosage compensation(GO:0007549) |
0.2 | 0.6 | GO:0034371 | chylomicron remodeling(GO:0034371) |
0.2 | 0.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 1.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 0.8 | GO:0048488 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.2 | 1.2 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 1.0 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.2 | 2.6 | GO:0042116 | macrophage activation(GO:0042116) |
0.2 | 0.4 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.2 | 0.2 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) inflammatory response to wounding(GO:0090594) |
0.2 | 1.6 | GO:0015671 | oxygen transport(GO:0015671) |
0.2 | 0.8 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 0.6 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 1.0 | GO:0045217 | cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
0.2 | 2.7 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.2 | 0.4 | GO:0044321 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.2 | 0.4 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.2 | 1.3 | GO:0006895 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.2 | 0.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.2 | 0.6 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.2 | 0.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 0.2 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.2 | 1.1 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.2 | 0.8 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 0.2 | GO:0033605 | positive regulation of catecholamine secretion(GO:0033605) |
0.2 | 0.6 | GO:0031060 | regulation of histone methylation(GO:0031060) |
0.2 | 0.4 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.2 | 1.5 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.2 | 0.7 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.2 | 0.6 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.2 | 0.2 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.2 | 2.4 | GO:0045730 | respiratory burst(GO:0045730) |
0.2 | 1.3 | GO:0009595 | detection of biotic stimulus(GO:0009595) |
0.2 | 0.5 | GO:0010587 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.2 | 0.4 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.2 | 2.0 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 1.2 | GO:0060736 | prostate gland growth(GO:0060736) |
0.2 | 1.8 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.2 | 0.5 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.2 | 0.2 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.2 | 0.5 | GO:0071436 | sodium ion export(GO:0071436) |
0.2 | 0.3 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.2 | 4.0 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.2 | 0.3 | GO:1900006 | positive regulation of dendrite morphogenesis(GO:0050775) positive regulation of dendrite development(GO:1900006) |
0.2 | 0.7 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.2 | 0.3 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.2 | 0.7 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.2 | 0.3 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.2 | 1.5 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.2 | 2.0 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.2 | 0.8 | GO:0001967 | suckling behavior(GO:0001967) |
0.2 | 0.3 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.2 | 0.2 | GO:0045414 | regulation of interleukin-8 biosynthetic process(GO:0045414) |
0.2 | 0.7 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.2 | 1.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 0.5 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.2 | 0.6 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 0.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.5 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) |
0.2 | 0.8 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.2 | 0.5 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.2 | 0.2 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.2 | 2.7 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.2 | 1.6 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.2 | 0.5 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.2 | 0.3 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.2 | 0.2 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.2 | 0.3 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
0.2 | 1.2 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.2 | 0.3 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.2 | 0.5 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 1.7 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.2 | 1.1 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.2 | 0.2 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.2 | 0.5 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.2 | 0.6 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 0.5 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.2 | 0.6 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.1 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.3 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) positive regulation of hormone biosynthetic process(GO:0046886) |
0.1 | 1.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.4 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 0.6 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.1 | 0.9 | GO:0061001 | dendritic spine development(GO:0060996) dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine development(GO:0060998) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.1 | 0.9 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.1 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.1 | 0.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.3 | GO:0042161 | plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.1 | 1.0 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.6 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.1 | 0.8 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.1 | 0.1 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.1 | 0.4 | GO:0051459 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.1 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) regulation of mesoderm development(GO:2000380) |
0.1 | 0.4 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 2.6 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 0.4 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.1 | 1.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.1 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.1 | 0.1 | GO:1903299 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 1.9 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.3 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 0.3 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 0.3 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.1 | GO:0048541 | Peyer's patch development(GO:0048541) |
0.1 | 0.4 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.1 | 0.4 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.1 | 1.7 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 0.4 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 | 0.7 | GO:0007320 | insemination(GO:0007320) |
0.1 | 0.5 | GO:0003351 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.3 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 1.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.1 | GO:0051593 | response to folic acid(GO:0051593) |
0.1 | 0.6 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.1 | 0.4 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.1 | 0.3 | GO:0046931 | pore complex assembly(GO:0046931) |
0.1 | 0.1 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.1 | 0.3 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.1 | 0.8 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.1 | GO:2000831 | corticosteroid hormone secretion(GO:0035930) regulation of steroid hormone secretion(GO:2000831) regulation of corticosteroid hormone secretion(GO:2000846) |
0.1 | 0.6 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.3 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.4 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.1 | GO:0002532 | production of molecular mediator involved in inflammatory response(GO:0002532) |
0.1 | 0.1 | GO:0042033 | chemokine biosynthetic process(GO:0042033) chemokine metabolic process(GO:0050755) |
0.1 | 1.7 | GO:0018904 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.1 | 0.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.4 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 1.9 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.1 | 0.5 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.2 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 0.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.6 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.1 | 0.2 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 0.6 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.2 | GO:0032760 | positive regulation of tumor necrosis factor production(GO:0032760) |
0.1 | 1.1 | GO:0060039 | pericardium development(GO:0060039) |
0.1 | 0.4 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 0.5 | GO:0015669 | gas transport(GO:0015669) |
0.1 | 0.4 | GO:0043584 | nose development(GO:0043584) |
0.1 | 0.6 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.8 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 | 6.0 | GO:0006826 | iron ion transport(GO:0006826) |
0.1 | 0.2 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.1 | 0.3 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.1 | 0.3 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.1 | 0.2 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.1 | 0.1 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.1 | 0.3 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 0.2 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.1 | 0.1 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.1 | 0.3 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.1 | 0.6 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.4 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.1 | 0.2 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.3 | GO:0035610 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.1 | 0.2 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.6 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.8 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.1 | 1.2 | GO:0001556 | oocyte maturation(GO:0001556) |
0.1 | 1.1 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 1.7 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.6 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.3 | GO:2000095 | regulation of non-canonical Wnt signaling pathway(GO:2000050) regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 1.3 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.1 | 0.4 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.1 | 0.4 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.6 | GO:0048260 | positive regulation of receptor-mediated endocytosis(GO:0048260) |
0.1 | 0.4 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 0.1 | GO:0050996 | positive regulation of lipid catabolic process(GO:0050996) |
0.1 | 0.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.3 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 0.5 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.3 | GO:1903313 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.1 | 1.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.4 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.5 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.1 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.1 | 0.3 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.1 | 0.2 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.1 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.1 | 0.1 | GO:0034143 | regulation of toll-like receptor 4 signaling pathway(GO:0034143) |
0.1 | 0.3 | GO:1903307 | positive regulation of regulated secretory pathway(GO:1903307) |
0.1 | 0.5 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.4 | GO:0021779 | oligodendrocyte cell fate commitment(GO:0021779) |
0.1 | 0.2 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 1.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.1 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 1.1 | GO:0045123 | cellular extravasation(GO:0045123) |
0.1 | 0.3 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.1 | 0.1 | GO:1904251 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.1 | 0.8 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.1 | 0.6 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.1 | 0.3 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.1 | 0.5 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.1 | GO:0060457 | negative regulation of digestive system process(GO:0060457) |
0.1 | 0.3 | GO:0042819 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.1 | 0.1 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
0.1 | 0.4 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.1 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.1 | GO:0032675 | regulation of interleukin-6 production(GO:0032675) |
0.1 | 0.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.1 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of pigment cell differentiation(GO:0050942) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.1 | 0.1 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.3 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.1 | GO:0032817 | regulation of natural killer cell proliferation(GO:0032817) |
0.1 | 0.2 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 0.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.3 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.3 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.1 | 0.3 | GO:0043552 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 0.8 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.1 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.1 | 0.3 | GO:0045006 | DNA deamination(GO:0045006) |
0.1 | 0.3 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.1 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 0.2 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.1 | 0.6 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.3 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.1 | 0.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.1 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.1 | 0.1 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.1 | 0.8 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.4 | GO:0060334 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 1.2 | GO:0035338 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.1 | 0.4 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.2 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 0.2 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.5 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.1 | 0.2 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.2 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.1 | 0.1 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.1 | 1.1 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.1 | 0.1 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 0.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.1 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.1 | 0.2 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) lymphocyte migration(GO:0072676) |
0.1 | 0.2 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.2 | GO:0016999 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.1 | 0.9 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.2 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.4 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.1 | 0.2 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 0.1 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.1 | 0.6 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.1 | 0.2 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.1 | 0.6 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.1 | 0.2 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.1 | 0.7 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.4 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 1.3 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 0.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.1 | GO:0046083 | adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.1 | 0.1 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.1 | 0.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.6 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.1 | 0.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.8 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.2 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.1 | 0.4 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.1 | 0.2 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 0.1 | GO:0034244 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.8 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.6 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.2 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.1 | 0.1 | GO:2000399 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.1 | 0.1 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 0.1 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.1 | 0.7 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 0.4 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.3 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 0.2 | GO:0006693 | prostaglandin metabolic process(GO:0006693) |
0.1 | 0.9 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.6 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.5 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.1 | 0.3 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.5 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.1 | 0.4 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.1 | 0.1 | GO:0009188 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.1 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.5 | GO:0070555 | response to interleukin-1(GO:0070555) |
0.1 | 0.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 0.2 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.1 | 0.1 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.1 | 0.1 | GO:0051324 | prophase(GO:0051324) |
0.1 | 0.3 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.2 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.3 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.1 | 0.6 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.2 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.1 | 0.1 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.1 | 0.4 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
0.1 | 0.1 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.3 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.5 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 1.3 | GO:0036503 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) |
0.1 | 0.1 | GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
0.1 | 0.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.2 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.1 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 0.1 | GO:0010939 | regulation of necrotic cell death(GO:0010939) |
0.1 | 0.2 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.2 | GO:0097035 | regulation of membrane lipid distribution(GO:0097035) |
0.1 | 0.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.2 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.7 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.1 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.1 | 0.7 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.1 | 0.6 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.3 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.1 | 0.3 | GO:0048753 | pigment granule organization(GO:0048753) |
0.1 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.1 | 0.1 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.6 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.5 | GO:0033574 | response to testosterone(GO:0033574) |
0.1 | 0.3 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.9 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.1 | 0.1 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.1 | 0.4 | GO:0006582 | melanin metabolic process(GO:0006582) |
0.1 | 0.1 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.1 | GO:0001820 | serotonin secretion(GO:0001820) |
0.1 | 1.1 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.2 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.9 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.2 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.1 | 0.1 | GO:0006863 | purine nucleobase transport(GO:0006863) adenine transport(GO:0015853) |
0.1 | 0.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.1 | GO:0045072 | regulation of interferon-gamma biosynthetic process(GO:0045072) |
0.1 | 1.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.3 | GO:0051567 | histone H3-K9 methylation(GO:0051567) histone H3-K9 modification(GO:0061647) |
0.1 | 1.4 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.1 | 0.1 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.1 | 0.8 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.1 | 0.2 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.3 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.2 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.1 | 1.4 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 9.6 | GO:0006954 | inflammatory response(GO:0006954) |
0.1 | 0.6 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.1 | 0.5 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.1 | 0.4 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.2 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.0 | 0.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.4 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.0 | 0.0 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.0 | 0.2 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.0 | 0.1 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.0 | 0.7 | GO:0097581 | lamellipodium assembly(GO:0030032) lamellipodium organization(GO:0097581) |
0.0 | 0.1 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 0.0 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament organization(GO:0031033) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.1 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.0 | 0.1 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 1.1 | GO:0051318 | G1 phase(GO:0051318) |
0.0 | 0.2 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 1.1 | GO:0042246 | tissue regeneration(GO:0042246) |
0.0 | 0.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.2 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.0 | 0.2 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.0 | 0.4 | GO:0046131 | pyrimidine ribonucleoside metabolic process(GO:0046131) |
0.0 | 1.2 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.0 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.0 | 0.1 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.0 | 0.0 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.1 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.0 | 0.2 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.0 | 0.1 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.0 | 0.3 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.2 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.2 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.0 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.0 | 0.1 | GO:0031641 | regulation of myelination(GO:0031641) |
0.0 | 0.2 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.1 | GO:0016233 | telomere capping(GO:0016233) protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.0 | 0.0 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.0 | 0.1 | GO:0043137 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.0 | 0.1 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.0 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.0 | 0.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.0 | GO:0031057 | negative regulation of histone modification(GO:0031057) |
0.0 | 3.1 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.0 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.0 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.0 | 0.6 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.0 | GO:0003171 | atrioventricular valve development(GO:0003171) atrioventricular valve morphogenesis(GO:0003181) |
0.0 | 0.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.0 | 0.3 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.2 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.4 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.1 | GO:1903077 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.0 | 0.1 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.3 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.0 | 1.1 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.0 | 0.3 | GO:0006195 | purine nucleotide catabolic process(GO:0006195) |
0.0 | 1.8 | GO:0048193 | Golgi vesicle transport(GO:0048193) |
0.0 | 0.0 | GO:0060346 | bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
0.0 | 0.7 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) histone lysine methylation(GO:0034968) |
0.0 | 0.4 | GO:0006942 | regulation of striated muscle contraction(GO:0006942) |
0.0 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.3 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.1 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
0.0 | 0.2 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.0 | 0.0 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.0 | 0.0 | GO:0014889 | muscle atrophy(GO:0014889) |
0.0 | 0.4 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.3 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.0 | 0.0 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.3 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.1 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
0.0 | 0.1 | GO:0042219 | sulfur amino acid catabolic process(GO:0000098) cellular modified amino acid catabolic process(GO:0042219) sulfur compound catabolic process(GO:0044273) |
0.0 | 0.2 | GO:0032770 | positive regulation of monooxygenase activity(GO:0032770) |
0.0 | 0.0 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.4 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.0 | 0.1 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.0 | GO:0070233 | negative regulation of lymphocyte apoptotic process(GO:0070229) negative regulation of T cell apoptotic process(GO:0070233) negative regulation of thymocyte apoptotic process(GO:0070244) negative regulation of leukocyte apoptotic process(GO:2000107) |
0.0 | 0.4 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.0 | 0.1 | GO:0030277 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.3 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.0 | 0.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.1 | GO:0061299 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.0 | GO:0070741 | response to interleukin-6(GO:0070741) |
0.0 | 0.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.0 | 0.2 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.1 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 0.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.1 | GO:0009750 | response to fructose(GO:0009750) |
0.0 | 0.1 | GO:0007099 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.0 | 0.2 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.0 | 0.1 | GO:0072506 | phosphate ion homeostasis(GO:0055062) divalent inorganic anion homeostasis(GO:0072505) trivalent inorganic anion homeostasis(GO:0072506) |
0.0 | 0.3 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.1 | GO:0032365 | intracellular lipid transport(GO:0032365) |
0.0 | 0.0 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.1 | GO:0017085 | response to insecticide(GO:0017085) |
0.0 | 0.6 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.0 | GO:0045979 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.1 | GO:0009147 | pyrimidine nucleoside triphosphate metabolic process(GO:0009147) |
0.0 | 0.6 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.1 | GO:0050860 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.0 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.1 | GO:0051298 | centrosome duplication(GO:0051298) |
0.0 | 0.1 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.0 | 0.1 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.0 | 0.2 | GO:0016571 | histone methylation(GO:0016571) |
0.0 | 0.0 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.0 | 0.1 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.0 | 1.5 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.1 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.0 | GO:0010626 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) regulation of glial cell proliferation(GO:0060251) negative regulation of glial cell proliferation(GO:0060253) |
0.0 | 0.0 | GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) |
0.0 | 0.1 | GO:0032528 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.0 | 0.0 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 8.8 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.2 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.0 | 0.2 | GO:0045980 | negative regulation of nucleotide metabolic process(GO:0045980) |
0.0 | 0.7 | GO:0010827 | regulation of glucose transport(GO:0010827) |
0.0 | 0.0 | GO:0052031 | modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) |
0.0 | 0.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.1 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.0 | 0.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.0 | GO:1903115 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.0 | 0.0 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.1 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 1.7 | GO:0006897 | endocytosis(GO:0006897) |
0.0 | 0.1 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.0 | 0.0 | GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of calcium ion import(GO:0090281) negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.0 | 0.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.2 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.0 | 0.0 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
0.0 | 0.1 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
0.0 | 0.1 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.0 | 0.0 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.1 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.1 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 1.9 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 0.2 | GO:0016925 | protein sumoylation(GO:0016925) |
0.0 | 0.6 | GO:0006898 | receptor-mediated endocytosis(GO:0006898) |
0.0 | 0.6 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.0 | 0.1 | GO:0002097 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.0 | 0.0 | GO:0010523 | negative regulation of calcium ion transport into cytosol(GO:0010523) |
0.0 | 0.1 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.0 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.0 | 0.0 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.0 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.0 | 0.3 | GO:0043297 | apical junction assembly(GO:0043297) |
0.0 | 0.1 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.0 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.4 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
0.0 | 0.0 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.0 | 0.0 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.0 | 0.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.1 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.7 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.1 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.0 | 0.0 | GO:0044818 | mitotic G2/M transition checkpoint(GO:0044818) |
0.0 | 0.7 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.1 | GO:0046855 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) inositol phosphate catabolic process(GO:0071545) |
0.0 | 0.0 | GO:0097576 | vacuole fusion(GO:0097576) |
0.0 | 0.2 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.0 | 0.0 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.1 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.1 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.0 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.0 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 0.5 | GO:0070820 | tertiary granule(GO:0070820) |
0.5 | 1.9 | GO:0033268 | node of Ranvier(GO:0033268) |
0.4 | 0.8 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.4 | 1.2 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.4 | 1.2 | GO:0032009 | early phagosome(GO:0032009) |
0.4 | 1.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.3 | 1.0 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.3 | 1.5 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.3 | 0.9 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 2.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 0.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 2.7 | GO:0042581 | specific granule(GO:0042581) |
0.3 | 1.0 | GO:0036126 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.2 | 1.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 1.4 | GO:0000805 | X chromosome(GO:0000805) |
0.2 | 0.7 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.2 | 1.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 1.1 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.2 | 0.6 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.2 | 0.9 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.2 | 0.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 0.6 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 1.2 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.2 | 0.9 | GO:0031082 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.2 | 0.6 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.2 | 0.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 0.2 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.2 | 1.4 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 0.7 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 3.0 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 1.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 0.2 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 0.2 | GO:0043209 | myelin sheath(GO:0043209) |
0.2 | 0.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 1.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.6 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.3 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 1.0 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 0.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.3 | GO:0002142 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.1 | 0.6 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.7 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 1.1 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.1 | 1.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 1.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 3.9 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 1.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 1.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.8 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 1.2 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 1.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.4 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 2.5 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.1 | GO:1903561 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.1 | 0.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 0.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.1 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.1 | 0.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.5 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.8 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.7 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 0.1 | GO:0042611 | MHC protein complex(GO:0042611) MHC class I protein complex(GO:0042612) |
0.1 | 0.1 | GO:0032059 | bleb(GO:0032059) |
0.1 | 0.3 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 2.1 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.7 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 1.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.4 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.5 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.7 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 1.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.5 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.1 | 0.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 1.4 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 1.0 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.9 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.3 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 3.0 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 1.2 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.1 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.1 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 0.4 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 1.9 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 0.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 0.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 2.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.2 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 0.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.3 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 0.4 | GO:0099738 | cell cortex region(GO:0099738) |
0.1 | 1.3 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.2 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.4 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 5.2 | GO:0030141 | secretory granule(GO:0030141) |
0.1 | 0.4 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.4 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 4.4 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.8 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.2 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.6 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.2 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 0.4 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 1.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.3 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.0 | 0.2 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 0.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 1.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.1 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.7 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 2.9 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.0 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.0 | 0.1 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.0 | 0.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.2 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.1 | GO:0043205 | fibril(GO:0043205) |
0.0 | 2.8 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.2 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 0.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.3 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.2 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.1 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.3 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.1 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 0.1 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.0 | GO:0043656 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 1.7 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 4.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.4 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.0 | 0.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 1.8 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.7 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.0 | 0.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.5 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.1 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.3 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.0 | 0.0 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.8 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.2 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.2 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 106.6 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.1 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 1.3 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.5 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 2.3 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 1.1 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 0.1 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.6 | GO:0019717 | obsolete synaptosome(GO:0019717) |
0.0 | 0.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.2 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.0 | 7.2 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.1 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.3 | GO:0005814 | centriole(GO:0005814) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 6.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.9 | 3.4 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.7 | 2.2 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.7 | 6.4 | GO:0019864 | IgG binding(GO:0019864) |
0.7 | 2.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.6 | 2.5 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.6 | 1.9 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.6 | 3.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.6 | 0.6 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.6 | 1.7 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.5 | 2.7 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.5 | 2.2 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.5 | 1.5 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.5 | 2.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.5 | 1.5 | GO:0043559 | insulin binding(GO:0043559) |
0.5 | 1.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.5 | 4.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.5 | 0.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.5 | 1.4 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.5 | 2.3 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.4 | 1.7 | GO:0051425 | PTB domain binding(GO:0051425) |
0.4 | 1.7 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.4 | 2.0 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.4 | 3.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.4 | 0.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.4 | 1.6 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.4 | 1.2 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.4 | 1.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.4 | 1.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.4 | 1.8 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.4 | 0.7 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.3 | 1.0 | GO:0052659 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.3 | 1.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.3 | 0.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 1.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.3 | 0.7 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.3 | 1.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 1.9 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.3 | 1.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.3 | 0.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.3 | 2.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.3 | 0.6 | GO:0035197 | siRNA binding(GO:0035197) |
0.3 | 0.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 1.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.3 | 1.5 | GO:0030955 | potassium ion binding(GO:0030955) |
0.3 | 0.9 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.3 | 1.5 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.3 | 1.7 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 0.8 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.3 | 2.8 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.3 | 1.7 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.3 | 0.8 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.3 | 3.8 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.3 | 1.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 0.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.3 | 1.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.3 | 1.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.3 | 1.0 | GO:0004340 | glucokinase activity(GO:0004340) |
0.3 | 0.8 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.3 | 1.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.3 | 1.3 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.3 | 0.8 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.3 | 1.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 0.7 | GO:0004875 | complement receptor activity(GO:0004875) |
0.2 | 0.7 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 0.7 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.2 | 2.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 1.7 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.2 | 1.0 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.2 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.2 | 0.7 | GO:0008061 | chitin binding(GO:0008061) |
0.2 | 0.9 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 1.2 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.2 | 0.7 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 1.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.2 | 1.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 0.7 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 0.7 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.2 | 0.5 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.2 | 2.7 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.2 | 0.9 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.2 | 0.7 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.2 | 2.9 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.2 | 0.9 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 1.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 0.4 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.2 | 1.3 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.2 | 2.0 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.2 | 1.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 0.7 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 0.9 | GO:0005497 | androgen binding(GO:0005497) |
0.2 | 9.7 | GO:0008009 | chemokine activity(GO:0008009) |
0.2 | 0.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 0.4 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 1.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 0.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 0.9 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.2 | 0.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 0.6 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.2 | 0.8 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 3.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.2 | 0.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.2 | 0.8 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 1.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 0.6 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 0.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 1.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 5.1 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.2 | 0.6 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 0.6 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.2 | 2.3 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.2 | 0.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 0.6 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.2 | 1.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.2 | 0.6 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.2 | 0.6 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.2 | 0.5 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
0.2 | 0.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 0.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 0.9 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 0.7 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.2 | 0.7 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.2 | 0.5 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 0.3 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.2 | 0.5 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 2.9 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 1.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.2 | 0.8 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 0.3 | GO:0016151 | nickel cation binding(GO:0016151) |
0.2 | 2.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 0.8 | GO:0019956 | chemokine binding(GO:0019956) |
0.2 | 1.3 | GO:0043176 | amine binding(GO:0043176) |
0.2 | 0.5 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 1.0 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 0.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 0.5 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 2.4 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.2 | 0.5 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.2 | 0.3 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
0.2 | 0.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 0.5 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.2 | 0.6 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 0.5 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.2 | 0.5 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 0.5 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 0.5 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.6 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.1 | 1.0 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 0.3 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 1.2 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.1 | 1.0 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 1.6 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 2.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.6 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 1.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.4 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 0.7 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 1.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 1.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.7 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 1.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.8 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.4 | GO:0046980 | tapasin binding(GO:0046980) |
0.1 | 0.4 | GO:0097493 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.4 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.1 | 0.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.1 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.1 | 0.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.5 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.5 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.5 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 0.1 | GO:0015421 | oligopeptide-transporting ATPase activity(GO:0015421) |
0.1 | 0.9 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.5 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.2 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.5 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.4 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 0.7 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.4 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.4 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.4 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.1 | 0.8 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 1.9 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 3.3 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 2.1 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.2 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 0.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 3.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.3 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 0.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.3 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.1 | 2.1 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.6 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.5 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 1.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.2 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.1 | 0.2 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
0.1 | 1.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.7 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.7 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.1 | 0.3 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.2 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 0.5 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.4 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 1.1 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.9 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 1.1 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.1 | 0.3 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 0.1 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 3.3 | GO:0004601 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.1 | 0.1 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.1 | 0.4 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.1 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.1 | 0.3 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.1 | 0.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.2 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 1.3 | GO:0004835 | tubulin-tyrosine ligase activity(GO:0004835) |
0.1 | 0.3 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 1.0 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 0.3 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 0.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.2 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.1 | 0.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.2 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.1 | 0.5 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.4 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.3 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 0.6 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 0.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.4 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.3 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.2 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 2.2 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 1.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 1.0 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 1.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.6 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.6 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.1 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.1 | 1.3 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.2 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.6 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.4 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.5 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 0.3 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.5 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.2 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.1 | 1.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 1.7 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 2.8 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.5 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 0.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.4 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.1 | 0.3 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 1.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 0.7 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 1.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 1.4 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 0.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.4 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 0.4 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 1.3 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.1 | 0.3 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.3 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.1 | 0.1 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.1 | 0.5 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.1 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 0.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.8 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 13.5 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 0.3 | GO:0004301 | epoxide hydrolase activity(GO:0004301) ether hydrolase activity(GO:0016803) |
0.1 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.2 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.1 | 0.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.9 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 1.0 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.1 | 0.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.3 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.1 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.1 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.3 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.2 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 1.1 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.3 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.1 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.1 | 0.2 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 0.2 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.1 | 0.4 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.4 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 0.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 1.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 1.0 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.3 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.8 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.3 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 0.8 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.7 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.6 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.4 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.1 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.0 | 0.0 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.8 | GO:0032934 | sterol binding(GO:0032934) |
0.0 | 0.9 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.8 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.0 | 0.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.6 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 3.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 9.7 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.5 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.8 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 1.0 | GO:0005506 | iron ion binding(GO:0005506) |
0.0 | 0.2 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 0.2 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 1.4 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.0 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.7 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.2 | GO:0080032 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.1 | GO:0030354 | melanin-concentrating hormone activity(GO:0030354) |
0.0 | 0.1 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.1 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 1.0 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.7 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.4 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 0.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.1 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.0 | 0.2 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 4.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.0 | 0.6 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 1.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.1 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.4 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.9 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.0 | GO:0008186 | RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 10.6 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.8 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.0 | 0.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.1 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.3 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.1 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.0 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.3 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.5 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.0 | 0.5 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 1.6 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.0 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 1.9 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.0 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.0 | 0.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.3 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.0 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.0 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.1 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.0 | 0.0 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.0 | 0.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.3 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.1 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.1 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.1 | GO:0010851 | cyclase regulator activity(GO:0010851) |
0.0 | 0.0 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.2 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.0 | 0.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.2 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.0 | 0.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 3.1 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.0 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.0 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.2 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.0 | GO:0016504 | peptidase activator activity(GO:0016504) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.4 | 1.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.4 | 1.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.4 | 12.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.3 | 10.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.3 | 1.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 1.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 7.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 1.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 1.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 1.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 0.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 0.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 0.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 1.9 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 2.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 1.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.7 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 1.5 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 1.5 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 6.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 0.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 4.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 1.8 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 0.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 0.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 0.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 0.8 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 1.5 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 0.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 1.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 2.7 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 1.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 1.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 1.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 1.3 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 1.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 2.0 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 1.9 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 8.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 1.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 1.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 10.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 1.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 1.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 1.4 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 9.0 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.7 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.2 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.3 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.0 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.2 | PID BCR 5PATHWAY | BCR signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.5 | 6.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 2.2 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.4 | 5.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.4 | 1.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 0.4 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.4 | 1.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.3 | 3.5 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.3 | 1.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.3 | 0.6 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.3 | 0.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.3 | 0.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 2.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 0.3 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.2 | 0.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 0.9 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 0.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 2.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 2.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 3.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 1.9 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.2 | 3.5 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 2.7 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.2 | 0.2 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.2 | 7.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 0.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 0.8 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 0.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.2 | 0.2 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 1.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 1.6 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 4.8 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 1.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 1.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 1.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 2.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 2.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 8.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 0.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 0.2 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.2 | 0.9 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 2.0 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.1 | 4.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 1.7 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 1.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 2.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.9 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 2.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 0.9 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 1.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.3 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 1.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 3.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 0.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 1.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 2.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 1.3 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 1.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.9 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.1 | 1.4 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 2.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 4.9 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 2.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 1.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 2.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 6.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 2.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 0.2 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.1 | 2.5 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.1 | 1.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 1.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 1.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.2 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 1.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 1.8 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 0.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 1.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.6 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 0.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.0 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 2.1 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.1 | 0.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.8 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 1.6 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 0.6 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 0.5 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 1.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 3.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 2.3 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.1 | 0.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 0.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.5 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 0.1 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.1 | 0.7 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 0.3 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.1 | 0.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 0.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 4.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.4 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 0.4 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 2.5 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 0.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 0.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.4 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 0.3 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 3.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 5.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 0.4 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
0.1 | 1.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 1.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 0.6 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.8 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.0 | 1.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 1.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.9 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.0 | 0.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.2 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.0 | 0.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.4 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.0 | 0.3 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.5 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.6 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 1.1 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 1.8 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.3 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 5.2 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.4 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 1.3 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.5 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 0.1 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 8.8 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.3 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 1.0 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.0 | 1.1 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.1 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.0 | 0.1 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 1.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.2 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.3 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.1 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.0 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.3 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 0.1 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |